NGM Biopharmaceuticals, Inc.
ILT3-BINDING AGENTS AND METHODS OF USE THEREOF

Abstract:

The present disclosure provides binding agents, such as antibodies, that specifically bind ILT3, including human ILT3, as well as compositions comprising the binding agents, and methods of their use. The disclosure also provides related polynucleotides and vectors encoding the binding agents and cells comprising the binding agents.